2Pereira RF, O'hara MD, Laptev AV, et al. marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues of osteogenesis imperfecta[J]. Pro Natl Acad Sci USA, 1998,95:1142.
3Horwitz EM, Prockop DJ, Fitzpatrick LA, et al. transplantability and therapeutic effects of bone marrow-de-rived mesenchymal cells in children with osteogenesis imperfecta[J]. Net Med, 1999,5:309.
4Kuivaniemi H, Tromp G, Prockop DJ. mutations in collagen genes: causes of rare and some common diseasea in humans[J]. FASEB J, 1991,5:2052.
5Wang Q, Marini JC. Antisense oligodeoxynucleotides selectively suppress expressin of the mutsnt al ( I ) collagen allele in type IV osteogenesis imperfecta fibroblasts.A molecular aproach to therapeutics of dominant negative disorders[J]. J Clin Invest, 1996,97 :448.
6Marini JC, Gerber NL. Osteogenesis imerfecta: rehabilitation and prospect for gene therapy[J]. JAMA, 1997,277:746.
7Grassi G, Forlino A, Marini JC. Cleavage of collagen RNA transcrips by hammerhead ribozymes in vitro is mutation-specific and shows competitive binding effects[J]. Nucleic Acid Res, 1997,25:3451.
8Balk ML, Bray J, Day C, et al. Effect of rhBMP-2 on osteogenic potential of bone marrow stromal cells from an oseogenesis imperfecta mouse[J]. Bone, 1997,21:7.
9Oyama M, Tatlock A, Fukuta S, et al. Retrovirally transduced bone marrow stromal cells isolated from a mouse model of human oeteogenesis imperfeeta (oim)persist in bone and retain the ability to form cartilage and bone after extended passaging[J]. Gene Ther, 1999,6 :321.
10Suzuki K, Oyama M, Faulcon L, et al. In vivo expression of human growth hormone by genetically modified murine bone marrow stromal cells and its effects on thecells in vitro[J]. Cell Transplanation In Press,2000.
